Relmada Therapeutics, Inc. (RLMD)

4.45 -0.38 (-7.87%) USD  |  NASDAQ  |  Jan 02, 11:37
More

Relmada Therapeutics EV to CFO

EV to CFO Chart

View EV to CFO for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to CFO Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Invivyd, Inc. Upgrade
Arcellx, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
Sensus Healthcare, Inc. Upgrade

EV to CFO Related Metrics

EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade